Laurus Labs receives EIR for API facility of Unit 2
On successful completion of USFDA inspection
Laurus Labs announced that the API facility of the Unit 2 has completed successful USFDA inspection without any 483 and the formulations unit in the same facility received EIR (Establishment Inspection Report) on 18 May 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content